NeuroScientific
NSB.AXNeuroScientific Biopharmaceuticals Limited Price (NSB.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
144,508,886
(0.723)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 116,000 | 38,025 | 28,876 | 33,849 | 0 | 958,769 | 0 | 4,952,959 | 0 |
| Net Income | -103,387 | -261,117 | -931,420 | -1,658,913 | -2,868,528 | -3,177,831 | -10,435,349 | -1,068,606 | 324,210 |
| FCF USD | -97,757 | -201,419 | -497,911 | -1,426,489 | -2,283,609 | -2,631,439 | -6,946,199 | -2,304,340 | 42,434 |
| OCF USD | -87,757 | -186,419 | -497,911 | -1,407,410 | -2,281,227 | -2,601,561 | -6,942,333 | -2,304,340 | 44,249 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| D/E | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CA/CL | 1.53 | 3.80 | 3.75 | 74.22 | 37.34 | 64.58 | 3.34 | 8.39 | 58.87 |
| TA/TL | 2.02 | 13.42 | 10.59 | 82.00 | 42.22 | 66.37 | 3.49 | 8.86 | 63.44 |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ROIC | -175.47% | -48.67% | -127.21% | -31.98% | -80.60% | -28.92% | -190.30% | -23.16% | 6.60% |
| ROE | -83.07% | -48.74% | -127.15% | -32.78% | -78.61% | -21.76% | -189.06% | -22.77% | 6.06% |
| ROA | 0.00% | -45.10% | -115.15% | -32.38% | -76.75% | -21.43% | -134.87% | -20.20% | 0.00% |
| NM % | -89.13% | -686.70% | -3,225.59% | -4,900.92% | - | -331.45% | - | -21.58% | - |
| FCF / R% | 0.00% | -529.70% | -1,724.31% | -4,214.27% | 0.00% | -274.46% | 0.00% | -46.52% | 0.00% |
| FCF / NI% | 94.55% | 77.14% | 53.46% | 85.99% | 79.61% | 82.81% | 66.56% | 215.64% | - |
| Operating Margin (OM) | 0.00 | -97.07 | -160.09 | -185.58 | - | -12.70 | - | -4.64 | - |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.00 | 0.00 | -0.03 | -0.02 | -0.04 | -0.02 | -0.07 | -0.01 | 0.00 |
| SPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.03 | 0.00 |
| OCPS | 0.00 | 0.00 | -0.02 | -0.02 | -0.03 | -0.02 | -0.05 | -0.02 | 0.00 |
| FCPS | 0.00 | 0.00 | -0.02 | -0.02 | -0.03 | -0.02 | -0.05 | -0.02 | 0.00 |
| BVPS | 0.00 | 0.01 | 0.02 | 0.07 | 0.05 | 0.10 | 0.04 | 0.03 | 0.04 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.00 | 0.00 | -0.03 | -0.02 | -0.04 | -0.02 | -0.07 | -0.01 | 0.00 |
| CAGR-SPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.03 | 0.00 |
| CAGR-OCPS | 0.00 | 0.00 | -0.02 | -0.02 | -0.03 | -0.02 | -0.05 | -0.02 | 0.00 |
| CAGR-FCPS | 0.00 | 0.00 | -0.02 | -0.02 | -0.03 | -0.02 | -0.05 | -0.02 | 0.00 |
| CAGR-BVPS | 0.00 | 0.01 | 0.02 | 0.07 | 0.05 | 0.10 | 0.04 | 0.03 | 0.04 |